Becker's Healthcare June 17, 2022
Giles Bruce

Ultima Genomics, a startup that has raised more than $600 million, said it plans to release a $100 genome, a step that could revolutionize disease diagnosis and precision medicine.

The company presented the first scientific results of its platform at the Advances in Genome Biology and Technology conference in early June. The early research has involved scientists from institutions such as the Broad Institute of MIT and Harvard, the Stanford Center for Genomics and Personalized Medicine and Baylor College of Medicine.

“DNA is nature’s storage media and the instruction set for every living organism, yet with current technologies, we can’t access that information at the scale needed to truly understand complex biology,” Gilad Almogy, Ultima...

Today's Sponsors

Oliver Wyman
Upfront Healthcare

Today's Sponsors


Today's Sponsor


Topics: Pharma / Biotech, Precision Medicine
Executive Interviews at Fierce Biotech Summit 2022
New AI precision medicine tool adopted by UCLA, Rush, other health systems
The American Heart Association Launches Precision Medicine Platform, New Proprietary Computational Models for Oncology Drug Discovery, More
Examining mRNA vaccine effectiveness for immunocompromised adults during omicron BA.4 and BA.5 predominance
Biotech's newest odd couple: A pharma insider and a music maven launch a health care VC